Physician profile
David A Lynch
NPI 1750452629
$187,733.08
in general payments reported to CMS, 2019-2025
11 companies · $14K in 2025
The $14K reported for 2025 was more than what 97% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $16K · 2021: $22K · 2022: $16K · 2023: $39K · 2024: $38K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $90K · Food and Beverage: $482 · Travel and Lodging: $89.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $90,422.75 |
| Food and Beverage | $482.21 |
| Travel and Lodging | $89.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $116,027.05 | 2020-2025 | Enhertu |
| Merck Sharp & Dohme LLC | $30,390.00 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18,259.44 | 2019-2024 | Ofev |
| Siemens Medical Solutions USA, INC. | $10,715.99 | 2019-2023 | Naeotom Alpha |
| Boehringer Ingelheim International Gmbh | $6,811.79 | 2019-2025 | Ofev |
| Boehringer Ingelheim Pharma Gmbh & Co.Kg | $2,550.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $1,835.00 | 2021 | |
| Insmed, INC. | $1,128.00 | 2025 | |
| Mylan Specialty L.P. | $15.81 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.